Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Satsuma Pharmaceuticals, Inc.:
We consent to the use of our report dated June 21, 2019, except as to the fifth paragraph of Note 14, which is as of September 11, 2019, incorporated by reference herein.
| /s/ KPMG LLP |
| San Diego, California |
| September 17, 2019 |
